Why it matters
The project concerns a potential medicine option for U.S. military personnel, but the article does not establish whether the wafer works or will be adopted. No immediate effect on patients or military care is reported.
MILITARY & VETERAN HEALTH • UNITED STATES
Pentagon funds development of ketamine wafer for battlefield use
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
BLUF
The Pentagon awarded a multimillion-dollar contract to Singapore-based iX Biopharma to develop a wafer containing ketamine for possible battlefield use, according to Defense News. The article provides no details on testing, approval or when the product might be available.
HOW THIS BRIEF WAS MADE 1 outlet: 1 trade press. Automated sourcing and summaries by the BLUF engine. Corrections